Perturbation of BRMS1 interactome reveals pathways that impact metastasis

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Breast Cancer Metastasis Suppressor 1 (BRMS1) expression correlates with improved patient survival across various cancers.
• Understanding BRMS1's function is key for developing novel therapeutic strategies against cancer metastasis.
• The C-terminus of BRMS1 is crucial for its metastasis-suppressing activity.

Purpose of the Study:

• To investigate the role of the BRMS1 C-terminus in mediating protein interactions essential for metastasis suppression.
• To elucidate how phosphorylation at serine 237 (S237) influences BRMS1's functional interactions and biological outcomes.

Main Methods:

• Confirmation of the C-terminus's role in metastasis suppression.
• Analysis of protein interactions regulated by S237 phosphorylation.
• Assessment of BRMS1's impact on MDA-MB-231 breast carcinoma cell migration and in vivo metastasis.

Main Results:

• Phosphorylation at S237 modulates BRMS1 interactions with proteins involved in cell cycle, DNA repair, and metastasis.
• The presence of S237 phosphorylation directly inhibited MDA-MB-231 breast carcinoma cell migration and in vivo metastasis.
• BRMS1 C-terminus interactions with Sin3/HDAC complexes were confirmed to regulate metastasis.

Conclusions:

• The C-terminus of BRMS1 is critical for metastasis suppression, mediated by specific protein interactions.
• Phosphorylation at S237 is a key regulatory mechanism controlling BRMS1's molecular functions and anti-metastatic effects.
• This study deepens the understanding of BRMS1's role in regulating cancer metastasis through distinct protein-protein interactions.